-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Aldeyra Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2014 to Q1 2025.
- Aldeyra Therapeutics, Inc. Depreciation for the quarter ending March 31, 2025 was $60.9K, a 0.46% increase year-over-year.
- Aldeyra Therapeutics, Inc. annual Depreciation for 2024 was $250K, a 5.01% decline from 2023.
- Aldeyra Therapeutics, Inc. annual Depreciation for 2023 was $263K, a 1.57% increase from 2022.
- Aldeyra Therapeutics, Inc. annual Depreciation for 2022 was $259K, a 2.07% decline from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)